Back
  • Share

EDCs & Female Reproductive Health: A growing health concern

Pollution, environmental and human health | Clinical impacts and solutions | Staying healthy and caring at home

Collaborative on Health and the Environment (CHE)
Collaborative on Health and the Environment (CHE)

Over the past several decades, human fertility rates have decreased while the incidence of female reproductive disorders has increased. A multitude of factors contribute to the decline of female fertility and reproductive health, including genetics, lifestyle, socioeconomic status, BMI, and age. However, a growing body of evidence suggests that endocrine-disrupting chemicals (EDCs) are an important contributor.

  • Date (DD-MM-YYYY)

    28-11-2025 to 28-11-2026

    Available on-demand until 28th November 2026

  • Cost

    Free

  • Education type

    Virtual

  • CPD subtype

    On-demand

Description

In this EDC Strategies Partnership webinar, Dr. Anne-Simone Parent, a researcher from the MERLON project, presented the findings from their recent review paper, "Endocrine-disrupting chemicals and female reproductive health: A growing concern." This highlights how EDCs impact the development of female reproductive disorders and the challenges behind proving the causality between exposure and human disease manifestation. The female reproductive disorders include abnormal puberty, impaired fertility, premature menopause or polycystic ovarian syndrome. The webinar was moderated by Génon Jensen, Executive Director, Health and Environment Alliance (HEAL).

About MERLON: The MERLON project - an EU funded research initiative, brings together world-leading experts from 12 partner institutions across Europe to develop and improve tools to better identify and ultimately regulate harmful endocrine disrupting chemicals (EDCs). It focuses on associations between exposure to endocrine disrupting chemicals and the impaired sexual development and reproductive functions in humans. It also works on the transition to applying new approach methodologies (NAMs), a new paradigm of chemical testing that aims to reduce our reliance on animals for toxicity testing.

Contact details